← Leaderboards
Karen Hansen
Ccs Associates, Inc.
$3,146,709
Attributed
$3,146,709
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $622K · FY2009–19$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,146,709 · 4
By mechanism
N01$2,920,197 · 2
N02$226,512 · 2
Top collaborators
No co-investigators on record.
Most similar at Ccs Associates, Inc.
Same institution · by research overlap
- Caroline C Sigman$32,114,409
- Caroline Sigman$38,271,961
- Lynn Thomas$294,194
- Linda Doody$342,493
- Robert Brakaj$156,415
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsResearch PersonnelServicesMedicalPrincipal InvestigatorDrug DevelopmentRegulatory AffairsDrug KineticsPharmacologic SubstancePharmaceutical ChemistryChemistryIndustryNeurosciencesInstitutesLeadDrug DiscoveryLeadershipClinical PharmacologyMapsNational Institute Of Neurological Disorders And StrokeDrug MetabolismContractsFundingNeurosciences Research
Grant awards (17)
IGF::OT::IGF, R&D - VASCULAR INTERVENTION/INNOVATIONS THERAPEUTIC ADVANCES$471,324
N01 · FY2019 · HL · contact PI
NINDS BPN REGULATORY AFFAIRS CONSULTANT CCS ASSOCIATES IGF::CL::IGF$80,778
N02 · FY2019 · DA · contact PI
NINDS BPN MEDICAL WRITING CONSULTANT IGF::CL::IGF$69,909
N02 · FY2019 · DA · contact PI
PROGRAM COORDINATING CENTER FOR VASCULAR INTERVENTION/INNOVATIONS THERAPEUTIC ADVANCES, VITA$459,920
N01 · FY2018 · HL · contact PI
NINDS BPN REGULATORY AFFAIRS CONSULTANT CCS ASSOCIATES IGF::CL::IGF$6,731
N02 · FY2018 · DA · contact PI
NINDS BPN MEDICAL WRITING CONSULTANT IGF::CL::IGF$2,996
N02 · FY2018 · DA · contact PI
IGF::OT::IGF, R&D - VASCULAR INTERVENTION/INNOVATIONS THERAPEUTIC ADVANCES$524,527
N01 · FY2017 · HL · contact PI
NINDS BPN REGULATORY AFFAIRS CONSULTANT CCS ASSOCIATES IGF::CL::IGF$14,961
N02 · FY2017 · DA · contact PI
NINDS BPN MEDICAL WRITING CONSULTANT IGF::CL::IGF$6,494
N02 · FY2017 · DA · contact PI
IGF::OT::IGF, R&D - VASCULAR INTERVENTION/INNOVATIONS THERAPEUTIC ADVANCES$437,794
N01 · FY2016 · HL · contact PI
NINDS BPN REGULATORY AFFAIRS CONSULTANT CCS ASSOCIATES IGF::CL::IGF$21,692
N02 · FY2016 · DA · contact PI
NINDS BPN MEDICAL WRITING CONSULTANT IGF::CL::IGF$4,994
N02 · FY2016 · DA · contact PI
IGF::OT::IGF, R&D - VASCULAR INTERVENTION/INNOVATIONS THERAPEUTIC ADVANCES$426,884
N01 · FY2015 · HL · contact PI
NINDS BPN REGULATORY AFFAIRS CONSULTANT CCS ASSOCIATES IGF::CL::IGF$14,961
N02 · FY2015 · DA · contact PI
NINDS BPN MEDICAL WRITING CONSULTANT IGF::CL::IGF$2,996
N02 · FY2015 · DA · contact PI
IGF::OT::IGF, R&D - VASCULAR INTERVENTION/INNOVATIONS THERAPEUTIC ADVANCES$524,766
N01 · FY2014 · HL · contact PI
LITERATURE SUMMARIES, ASSESSMENTS, FOR BEST PHARMACEUTICALS FOR CHILDREN ACT$74,982
N01 · FY2009 · HD · contact PI